Key Record Dates
| ClinicalTrials.gov Identifier: | NCT02411656 |
|---|---|
| Brief Title: | Pembrolizumab in Treating Patients With Stage IV Metastatic or Recurrent Inflammatory Breast Cancer or Triple-Negative Breast Cancer Who Have Achieved Clinical Response or Stable Disease to Prior Chemotherapy |
| First Submitted : | April 3, 2015 |
| First Submitted that Met QC Criteria : | April 3, 2015 |
| First Posted : | April 8, 2015 (Estimate) |
| Last Update Submitted that Met QC Criteria : | December 4, 2020 |
| Last Update Posted : | December 7, 2020 |